ImmunOs Therapeutics raised $11M in Series C funding led by Gimv, Pfizer Ventures, and Mission BioCapital to advance its clinical trial for IOS-1002.
Amount Raised
$11 Million
Round Type
Series C
Investors
Description
ImmunOs Therapeutics, a Switzerland-based biopharmaceutical company, raised $11M in Series C funding. The company plans to use the capital to complete the Phase Ia dose escalation clinical trial of its lead program IOS-1002.
Quick answer
ImmunOs Therapeutics AG raised $11 Million in a Series C round, dated September 17, 2024. Investors: Double Point Ventures, Bio Med Partners, Mission Bio Capital, Pfizer Ventures and Gimv.
- How much did ImmunOs Therapeutics AG raise?
- ImmunOs Therapeutics AG raised $11 Million in a Series C round on September 17, 2024.
- Who invested in ImmunOs Therapeutics AG?
- Double Point Ventures, Bio Med Partners, Mission Bio Capital, Pfizer Ventures and Gimv are named as investors in this round.
- What does ImmunOs Therapeutics AG do?
- ImmunOs Therapeutics is a biopharmaceutical company leveraging its unique immune system modulating HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases.
- Who are the decision-makers at ImmunOs Therapeutics AG?
- Fundz holds 1 contact at ImmunOs Therapeutics AG. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ImmunOs Therapeutics AG that raised within 45 days of this round, from Fundz verified event records.
- Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.
- Archon Biosciences raised $20M (Seed) on October 30, 2024.
- Tempero Bio raised $77M on October 30, 2024.
- SynOx Therapeutics raised $92M (Series B) on October 30, 2024.
- Pathos AI raised $62M (Series C) on October 29, 2024.
- CrossBridge Bio raised $11M on October 29, 2024.
Who to call at ImmunOs Therapeutics AG, and when
A new round usually means ImmunOs Therapeutics AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImmunOs Therapeutics AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImmunOs Therapeutics AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImmunOs Therapeutics AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImmunOs Therapeutics AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ImmunOs Therapeutics AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.